<\/p>\n
What arrives as a handful of unrelated complaints is usually one hormonal shift with several addresses. Davie, FL dermatologist Lesley Clark-Loeser, MD explains what\u2019s underneath it: Declining estrogen affects collagen production, elastin organization, hyaluronic acid content, barrier function, wound healing and the fibroblasts responsible for maintaining healthy skin. \u201cThe result is not simply \u2018aging,\u2019 but a distinct shift in the biology of skin that requires a different treatment approach,\u201d she says.<\/p>\n
The losses also arrive fast. Dr. Day puts it at 30\u201350% of collagen in the first five years after menopause, then roughly 2% a year after that. Published figures land in the same range. Reviews of estrogen-deficient skin put dermal collagen loss at up to 30% in the first five years after menopause and about 2.1% a year after that, with skin thickness falling roughly 1.1% annually.<\/p>\n<\/div>\n
\u201cWomen today are seeking consultation earlier, often during perimenopause rather than waiting until changes become advanced,\u201d Dr. Clark-Loeser says. \u201cThere is much greater appreciation that maintaining healthy skin is often easier than trying to reverse years of accumulated change.\u201d<\/p>\n
The numbers track with what she sees. In NewBeauty\u2019s State of Aesthetics Summer 2026 report, 34.1% of women said their 40s are when aesthetic priorities feel most urgent, and another 28.8% named their 50s. Nearly two thirds are pointing at the decades perimenopause and menopause arrive in. From there the interest gets specific: 70.8% want topical skin care formulated for menopausal skin and 76.6% are open to energy-based treatments like lasers and radio-frequency microneedling. Only 7.2% said they want to age without any aesthetic help at all.<\/p>\n
Their goals have changed too. \u201cThey\u2019re asking about skin thinning, crepey texture, changes in pigmentation, slower healing, facial volume loss, and hair thinning,\u201d Dr. Clark-Loeser says, and they want plans \u201cthat support long-term skin health rather than relying on a single procedure.\u201d<\/p>\n
Dr. Day sees a second shift, this one on her side of the table. \u201cWe\u2019re now often the key in putting that puzzle together,\u201d she says. That means asking about sleep, mood, memory and joint changes, and recognizing when what shows up in the skin may be part of a larger hormonal picture.<\/p>\n
Ask a woman in this stage what bothers her and hair surfaces fast. \u201cThey feel their hair thinning, and that\u2019s another big issue,\u201d Dr. Day says. Some are dealing with telogen effluvium set off by hormonal fluctuation. Others see steady thinning with no shedding event to point to.<\/p>\n
It\u2019s the same shift on different tissue. \u201cEstrogen receptors are present throughout the skin and hair follicle, so hormonal changes influence multiple tissues simultaneously,\u201d Dr. Clark-Loeser says. \u201cHair may also become finer and less dense.\u201d Which is why hair is increasingly folded into the plan rather than handed off. \u201cSimilar regenerative approaches are increasingly being used to support hair density in appropriately selected patients,\u201d she says.<\/p>\n
If menopause is changing several tissues at once, no single product answers it. Dr. Day does a full assessment, then builds a plan for the year. \u201cIt\u2019s always multi-layered because what\u2019s happening is multi-layered,\u201d she says. Skin care, devices, lasers and injectables, prioritized against the patient\u2019s health, motivation and budget. Dr. Clark-Loeser works the same way. \u201cRather than thinking about one treatment replacing another, I think about how they work together,\u201d she says.<\/p>\n
That broader thinking is beginning to extend beyond individual practices, too. Revance, for example, works across aesthetics and regenerative medicine, two areas that increasingly intersect as providers think more holistically about midlife changes.<\/p>\n
For most women in this age group, the goal isn\u2019t more volume. It\u2019s support nobody can identify. Dr. Day reaches for hyaluronic acid filler more than anything else in her practice, particularly around the mouth. That\u2019s the area she says drives women the most crazy: fine vertical lines on the upper lip, in women who never smoked.<\/p>\n
She delivers it with a cannula and doesn\u2019t chase individual lines. For these patients, she says her product selection and technique are centered on support rather than obvious volume. \u201cIt doesn\u2019t add bulk or weight. It adds support.\u201d The same thinking applies in the lips, where she\u2019s after hydration rather than size. \u201cThis age group really doesn\u2019t want big lips. They just want hydrated lips, pretty lips, and they want the support around their mouth.\u201d She treats the whole perioral region as one aesthetic unit rather than a set of lines.<\/p>\n
\u201cGLP-1 medications have added an important new consideration because many women are now experiencing two biologic transitions simultaneously: menopause and weight loss,\u201d Dr. Clark-Loeser says.<\/p>\n
The two compound each other. \u201cWeight reduction offers tremendous health benefits, but significant or rapid loss of facial fat can accelerate visible volume depletion, making menopausal changes appear more pronounced,\u201d she says. \u201cAt the same time, the underlying hormonal changes associated with menopause continue to affect collagen, skin thickness, hydration, and elasticity.\u201d<\/p>\n
Her answer isn\u2019t to lose less weight. It\u2019s to stop treating the two transitions as separate problems. \u201cAs physicians, we need to evaluate the whole patient rather than treating each issue independently,\u201d she says. \u201cThe goal is not to reverse healthy weight loss, but to help patients maintain skin quality, facial balance, and overall vitality while they improve their health.\u201d<\/p>\n
Here\u2019s the newest part of the expectation: women want the hormone conversation to be part of the aesthetic conversation.<\/p>\n
Dr. Day\u2019s proactive plan starts before any treatment. \u201cOne is to recognize it. So, I help people recognize it. That\u2019s the first step,\u201d she says. The second is finding the right prescriber, \u201cGYNs or functional medicine doctors who are comfortable with and know how to prescribe menopause hormone therapy, because the earlier you start, the better.\u201d<\/p>\n
She refers this out constantly and gains nothing from it. \u201cI think women are being served so poorly,\u201d she says. \u201cThere\u2019s nothing in it for me. I\u2019m just helping them understand. But every single time they come back and say thank you, like they go out of their way to come back to say it changed my life.\u201d<\/p>\n
Perhaps the biggest change isn\u2019t a procedure at all. \u201cMenopause is not the beginning of decline,\u201d Dr. Clark-Loeser says. \u201cPerimenopause and menopause are the beginning of a new chapter that deserves a personalized strategy.\u201d<\/p>\n
That strategy starts with skin health, then gets individualized around each woman\u2019s anatomy, goals, lifestyle, hormonal status and rate of change. \u201cRather than chasing every new concern as it appears, I encourage patients to think about maintaining healthy tissue over time.\u201d<\/p>\n
\u201cUltimately, the goal isn\u2019t to look younger than your age. It\u2019s to look healthy, vibrant, and authentically like yourself throughout every stage of life\u2026and maybe that means looking younger than your chronological age too!\u201d<\/p>\n
All of that assumes the provider on the other side of the consultation knows what to look for, and that is where the field is behind. Dr. Day is blunt about it. \u201cWe\u2019re really good at the treatments we\u2019re doing, but we\u2019re masking perimenopause instead of fully addressing it,\u201d she says.<\/p>\n
A woman arriving in perimenopause now expects her provider to connect skin, hair, hormones and, increasingly, GLP-1-related change, and to understand how those pieces fit together. Recognizing that pattern is not yet standard across aesthetic medicine. Closing that gap will require a broader approach to the patient, one that considers what may be driving the changes rather than treating each concern in isolation.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"
What arrives as a handful of unrelated complaints is us […]<\/p>\n","protected":false},"author":1,"featured_media":3362,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[55],"tags":[],"_links":{"self":[{"href":"https:\/\/nichebeaty.com\/index.php\/wp-json\/wp\/v2\/posts\/3361"}],"collection":[{"href":"https:\/\/nichebeaty.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nichebeaty.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nichebeaty.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nichebeaty.com\/index.php\/wp-json\/wp\/v2\/comments?post=3361"}],"version-history":[{"count":0,"href":"https:\/\/nichebeaty.com\/index.php\/wp-json\/wp\/v2\/posts\/3361\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nichebeaty.com\/index.php\/wp-json\/wp\/v2\/media\/3362"}],"wp:attachment":[{"href":"https:\/\/nichebeaty.com\/index.php\/wp-json\/wp\/v2\/media?parent=3361"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nichebeaty.com\/index.php\/wp-json\/wp\/v2\/categories?post=3361"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nichebeaty.com\/index.php\/wp-json\/wp\/v2\/tags?post=3361"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}